<DOC>
	<DOCNO>NCT02534610</DOCNO>
	<brief_summary>Evaluation efficacy preemptive versus postoperative administration etoricoxib total knee arthroplasty ( TKA ) .</brief_summary>
	<brief_title>Analgesic Benefit Preoperative vs. Postoperative Etoricoxib Total Knee Arthroplasty</brief_title>
	<detailed_description>The investigator conduct prospective randomize control study 165 patient American Society Anesthesiologists ( ASA ) score I-III schedule primary TKA , divide 3 group : group A ( Etoricoxib 120 mg orally one hour surgery ) , group B ( Etoricoxib 120 mg orally end surgery ) group C placebo . Surgery perform spinal anesthesia . All group receive postoperative analgesia Numeric Rating Scale ( NRS ) 3 intravenous ( IV ) Perfalgan morphine demand follow 48 h. The effectiveness evaluate time initiation spinal anesthesia first analgesic dose NRS &gt; 3 , total amount morphine first 24 48 hour postoperative , side effect necessary amount adjuvant medication .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>ASA IIII weight ( kilo ) 40 kg height ( centimeter ) 155 cm nonanemic indication primary TKA ( total knee arthroplasty ) history asthma peptic ulcer severe hepatic renal dysfunction neuropathy bleed disorder uncooperative drug abuse sensibility etoricoxib paracetamol morphine long act nonsteroidal antiinflammatory drug ( NSAID ) last 4 day preoperative cerebrovascular peripheric vascular disease arterial hypertension ( HTA ) adequately control congestive heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>preemptive</keyword>
	<keyword>postoperative pain</keyword>
	<keyword>etoricoxib</keyword>
</DOC>